Cryptosporidium Species in Sohag Governorate

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-01

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cryptosporidium species are increasingly recognized as important enteric pathogens that infect a broad range of hosts including human, domestic and wild animals worldwide, causing asymptomatic or mild-to-severe gastrointestinal disease in their host species.

There are 38 species of Cryptosporidium that have been described, going from amphibian parasites to mammals ones, with over 40 genotypes infecting mammals, although Cryptosporidium parvum and Cryptosporidium hominis are the two species predominantly reported in human infections. In Cairo and Sharkyia governorates in Egypt, Cryptosporidium is a common intestinal parasite among children, especially in diarrheic, preschool-aged children, with a predominance of C. hominis indicates anthroponotic rather than zoonotic transmission. Also in the sohag governorate, Cryptosporidium infection is a common intestinal parasite, as in the last five years its prevalence about 35% but there is no study clarify predominant genotype of Cryptosporidium in sohag.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transmission and the Respiratory Tract in Cryptosporidiosis

NCT00507871

Cryptosporidiosis

COMPLETED

Cryptosporidiosis and Enteropathogens in Bangladesh

NCT02764918

Cryptosporidiosis

ACTIVE_NOT_RECRUITING

Anisakis Blastocystis Cryptosporidium Fish Prevalence

NCT02661074

Anisakis Allergy Occupational Exposure

COMPLETED

Anisakis Blastocystis Cryptosporidium Fish Serology

NCT02666092

Allergy to Fish Allergy Anisakis

COMPLETED

Treatment of Cryptosporidiosis

NCT04103216

Cryptosporidiosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cryptosporidiosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age: any age
2. Sex: male -female
3. Residence: rural-urban
4. Animal contact.
5. Immune status: immunocompetent - immunocompromised
6. Clinical manifestations: diarrhea -abdominal pain- fever- vomiting.